Rapid Deployment Vaccine Collaborative information
COVID-19 vaccine research organization
Rapid Deployment Vaccine Collaborative
Abbreviation
RaDVaC
Formation
March 2020
Type
501(c)(3) organization
Purpose
To design, produce, test, and share open-source vaccine research in an effort to accelerate and strengthen COVID-19 vaccine development
Key people
Preston Estep, Alexander Hoekstra, Don Wang, Ranjan Ahuja, Brian M. Delaney, George Church
Website
radvac.org
The Rapid Deployment Vaccine Collaborative (RaDVaC), is a non-profit, collaborative, open-source vaccine research organization founded in March 2020 by Preston Estep and colleagues from various fields of expertise, motivated to respond to the COVID-19 pandemic through rapid, adaptable, transparent, and accessible vaccine development.[1][2][3][4][5][6][7][8][9] The members of RaDVaC contend that even the accelerated vaccine approvals, such as the FDA's Emergency Use Authorization, does not make vaccines available quickly enough.[10] The core group has published a series of white papers online,[11] detailing both the technical principles of and protocols for their research vaccine formulas, as well as dedicated materials[12] and protocols[13] pages. All of the organization's published work has been released under Creative Commons non-commercial licenses, including those contributing to the Open COVID Pledge.[14] Multiple individuals involved with the project have engaged in self-experimentation to assess vaccine safety and efficacy. As of January 2022, the organization has developed and published twelve iterations of experimental intranasal, multivalent, multi-epitope peptide vaccine formulas, and according to the RaDVaC website, by early 2021 hundreds of individuals had self-administered one or more doses of the vaccines described by the group.
^"'Warp speed' is too slow for scientists testing COVID-19 vaccine on themselves". Archived from the original on 2020-11-28. Retrieved 2020-12-16.
The RapidDeploymentVaccineCollaborative (RaDVaC), is a non-profit, collaborative, open-source vaccine research organization founded in March 2020 by...
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness...
rapid deployment, if proven to be safe and effective coordinate with the Department of Defense for vaccine supply, production, and deployment around...
Reversal Network, founded by Faloon. In 2020, he joined the RapidDeploymentVaccineCollaborative (RaDVaC). Site Magazine Swedish Hegel Society Infinite Faculty...
Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses...
because it was the first time a typhoid vaccine was deployed during a civilian outbreak. Almoth Edward Wright's vaccine was offered to 200 healthcare providers...
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech....
Global Fund to Fight AIDS, Tuberculosis and Malaria; UNICEF; Gavi, the Vaccine Alliance; the U.S. Centers for Disease Control and Prevention; the Bill...
evaluation of vaccine safety profiles through preclinical and clinical studies is essential to mitigate potential risks and ensure the deployment of safe and...
advance scientific research. Without the collaborative efforts of such entities, the world would not have the vaccines and treatments we now possess for diseases...
National Institute of Allergy and Infectious Diseases. Some of MHRP's collaborativevaccine-as-treatment research is funded by Janssen, a division of Johnson...
on April 14, 2021. Retrieved August 21, 2021. "These States Have Banned Vaccine Passports". U.S. News & World Report. June 1, 2021. Archived from the original...
FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac (Persian:...
a "molecular clamp" vaccine platform, that CEPI described as a "transformative technology that enables targeted and rapidvaccine production against multiple...